Table 1.
Group | Robuvit | Placebo | p |
---|---|---|---|
n | 33 | 33 | |
Age in years ± SD | 51.0 ± 9.1 | 50.3 ± 9.0 | 0.135 |
BMI ± SD | 27.3 ± 5.3 | 27.1 ± 4.9 | 0.563 |
BMI—body mass index (weight (kg)/height (m2)), p—significance, n—number of patients, SD—standard deviation.
Group | Robuvit | Placebo | p |
---|---|---|---|
n | 33 | 33 | |
Age in years ± SD | 51.0 ± 9.1 | 50.3 ± 9.0 | 0.135 |
BMI ± SD | 27.3 ± 5.3 | 27.1 ± 4.9 | 0.563 |
BMI—body mass index (weight (kg)/height (m2)), p—significance, n—number of patients, SD—standard deviation.